Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders

NCT01659840 | Completed DMC

• 1 other identifier: senhaodf
• Study Type: interventional
• Target: 116
• Locations: 1 country
• Sites: 1

Brief Summary

The study hypothesis was that the red (600nm) and infrared (800nm) laser therapy have the same efficacy in relieving pain and improving the quality of life of TMD patients

Conditions

Temporomandibular Disorders

Keywords

laser,; quality of life,; orofacial pain

Outcome Measures

Primary Outcomes (1)

• pain points of muscle and articulation

  180 days

Secondary Outcomes (1)

• Quality of life

  180 days

Study Arms (2)

Red laser

OTHER

On the pain points of muscle, laser was applied (8J/cm ²) with an interval of 48 hours between applications. In the joints with sensitivity, a dose of 4J/cm2 laser was applied with an interval of 48 hours between applications.

Radiation: Red laser

Infrared laser

OTHER

On the pain points of muscle, laser was applied (8J/cm ²) with an interval of 48 hours between applications. In the joints with sensitivity, a dose of 4J/cm2 laser was applied with an interval of 48 hours between applications.

Radiation: Infrared laser

Interventions

Red laser RADIATION

On the pain points of muscle, laser was applied (8J/cm ²) with an interval of 48 hours between applications. In the joints with sensitivity, a dose of 4J/cm2 laser was applied with an interval of 48 hours between applications.

Red laser

Infrared laser RADIATION

On the pain points of muscle, laser was applied (8J/cm ²) with an interval of 48 hours between applications. In the joints with sensitivity, a dose of 4J/cm2 laser was applied with an interval of 48 hours between applications.

Infrared laser

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• systemic health;
• Temporomandibular Disorder diagnosed by the Research Diagnostic Criteria for Temporomandibular Disorders questionnaire (RDC);
• pain score ≥ 5 on palpation according to a visual and numerical scale (VNS)

You may not qualify if:

• participants who made frequent use of analgesics, NSAIDs and antidepressants;
• patients with previously undergone TMD treatment, or suffered facial trauma

Sponsors & Collaborators

• Federal University of São Paulo: lead

Study Sites (1)

Periodontics Clinic, Department of Dentistry

Diamantina, Minas Gerais, 39100000, Brazil

Location

MeSH Terms

Conditions

Temporomandibular Joint Disorders; Facial Pain

Condition Hierarchy (Ancestors)

Craniomandibular Disorders; Mandibular Diseases; Jaw Diseases; Musculoskeletal Diseases; Joint Diseases; Muscular Diseases; Stomatognathic Diseases; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Olga D Flecha, Professor

  Federal University of the Valleys of Jequitinhonha and Mucuri

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: August 6, 2012
• First Posted: August 8, 2012
• Study Start: September 1, 2010
• Primary Completion: November 1, 2010
• Study Completion: November 1, 2010
• Last Updated: August 8, 2012

Record last verified: 2012-08

Locations

BR (1)